 |
市場調查報告書
商品編碼
2056089
2026-2030年全球細菌性疾病診斷市場Global Bacterial Disease Diagnostics Market 2026-2030 |
||||||
全球細菌性疾病診斷市場預計將從 2025 年到 2030 年成長至 49.96 億美元，預測期內複合年成長率為 6.9%。
本報告對全球細菌性疾病診斷市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。
本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括目標感染疾病率上升、病原體全球爆發、抗菌素抗藥性的快速蔓延和公共衛生法規的訂定、分子檢測技術的應用以及即時檢測技術的創新。
本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告同時呈現了歷史市場規模數據和預測市場規模數據。
| 市場範圍 | |
|---|---|
| 基準年 | 2025 |
| 年末 | 2030 |
| 調查期 | 2026-2030 |
| 成長勢頭 | 加速度 |
| 2026 年同比比較 | 6.6% |
| 複合年成長率 | 6.9% |
| 增量 | 49.96億美元 |
本研究指出，高通量多重症候群檢測技術的普及是未來幾年全球細菌性疾病診斷市場成長的關鍵促進因素之一。此外，人工智慧和機器學習在分散式表現型分析中的應用、微流體即時檢測技術的快速發展以及持續的監管協調，預計也將產生巨大的市場需求。
目錄
第1章執行摘要
第2章 Technavio 分析
- 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
- 輸入的重要性及差異化因素
- 干擾因素
- 促進因素和挑戰的影響
第3章 市場狀況
- 市場生態系統
- 市場特徵
- 價值鏈分析
第4章 市場規模
- 市場的定義
- 市場區隔分析
- 2025年市場規模
- 市場展望，2025-2030年
第5章 市場規模與表現
- 2020-2024年全球細菌性疾病診斷市場
- 產品細分市場分析，2020-2024 年
- 2020-2024 年最終用戶細分市場分析
- 按方法分類的細分市場分析，2020-2024 年
- 2020-2024年基於疾病類型的細分市場分析
- 區域區隔市場分析，2020-2024 年
- 2020-2024年各國細分市場分析
第6章 定性分析
- 人工智慧的影響：全球細菌性疾病診斷市場
- 地緣政治衝突對全球細菌性疾病診斷市場的影響。
第7章：五力分析
第8章 市場區隔：依產品
- 比較：按產品
- 消耗品
- 裝置
- 市場機會：依產品分類
第9章 市場區隔：依最終用戶分類
- 比較：按最終用戶
- 醫院
- 實驗室
- 市場機會：依最終用戶分類
第10章 市場區隔：依方法
- 比較：依方法
- 文化與隔離
- 顯微鏡
- 分子診斷
- 血清學檢測
- 其他
- 市場機會：依方法
第11章 市場區隔：依疾病類型
- 比較：依疾病類型
- 呼吸道感染疾病
- 胃腸道感染疾病
- 泌尿生殖系統感染疾病
- 皮膚和軟組織感染疾病
- 其他
- 市場機會：依疾病類型分類
第12章 客戶狀況
第13章 區域情勢
- 區域分類
- 區域比較
- 北美洲
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 亞洲
- 中國
- 印度
- 日本
- 韓國
- 印尼
- 泰國
- 世界其他地區（RoW）
- 巴西
- 沙烏地阿拉伯
- UAE
- 土耳其
- 阿根廷
- 哥倫比亞
- 南非
- 以色列
- 市場機會：按地區分類
第14章 促進因素、挑戰與機遇
- 市場促進因素
- 市場挑戰
- 促進因素和挑戰的影響
- 市場機遇
第15章 競爭格局
- 概述
- 競爭格局
- 混亂局面
- 產業風險
第16章 競爭分析
- 公司簡介
- 公司排名指標
- 企業市場定位
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- Bruker Corp.
- Cepheid Inc.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- QIAGEN NV
- QuidelOrtho Corp.
- Seegene Inc.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
第17章附錄
The global bacterial disease diagnostics market is forecasted to grow by USD 4996 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of target infectious diseases and global pathogen outbreaks, accelerated proliferation of antimicrobial resistance and public health mandates, technological integration of molecular assays and point of care testing innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.6% |
| CAGR | 6.9% |
| Incremental Value | $4996 mn |
Technavio's global bacterial disease diagnostics market is segmented as below:
By Product
- Consumables
- Instruments
By End-User
- Hospitals
- Labs
By Method
- Culture and isolation
- Microscopy
- Molecular diagnostics
- Serological testing
- Others
By Disease Type
- Respiratory infections
- Gastrointestinal infections
- Genitourinary infections
- Skin and soft tissue infections
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the shift towards high-throughput syndromic multiplex testing panels as one of the prime reasons driving the global bacterial disease diagnostics market growth during the next few years. Also, expansion of ai and ml in decentralized phenotypic profiling and accelerated proliferation of microfluidic poc assays and regulatory harmonization will lead to sizable demand in the market.
The report on the global bacterial disease diagnostics market covers the following areas:
- Global bacterial disease diagnostics market sizing
- Global bacterial disease diagnostics market forecast
- Global bacterial disease diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bacterial disease diagnostics market vendors that include Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., Cepheid Inc., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Hardy Diagnostics, Hologic Inc., Liofilchem Srl, Meridian Bioscience Inc., QIAGEN N.V., QuidelOrtho Corp., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.. Also, the global bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Method
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Bacterial Disease Diagnostics Market 2020 - 2024
- Historic Market Size - Data Table on Global Bacterial Disease Diagnostics Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Method segment analysis 2020 - 2024
- Historic Market Size - Method Segment 2020 - 2024 ($ million)
- 5.5 Disease Type segment analysis 2020 - 2024
- Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
- 5.6 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.7 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global bacterial disease diagnostics market
- 6.2 Impact of geopolitical conflicts on global bacterial disease diagnostics market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Consumables - Market size and forecast 2025-2030
- 8.4 Instruments - Market size and forecast 2025-2030
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2025-2030
- 9.4 Labs - Market size and forecast 2025-2030
- 9.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Method
- 10.1 Market segments
- 10.2 Comparison by Method
- 10.3 Culture and isolation - Market size and forecast 2025-2030
- 10.4 Microscopy - Market size and forecast 2025-2030
- 10.5 Molecular diagnostics - Market size and forecast 2025-2030
- 10.6 Serological testing - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Method
- Market opportunity by Method ($ million)
11 Market Segmentation by Disease Type
- 11.1 Market segments
- 11.2 Comparison by Disease Type
- 11.3 Respiratory infections - Market size and forecast 2025-2030
- 11.4 Gastrointestinal infections - Market size and forecast 2025-2030
- 11.5 Genitourinary infections - Market size and forecast 2025-2030
- 11.6 Skin and soft tissue infections - Market size and forecast 2025-2030
- 11.7 Others - Market size and forecast 2025-2030
- 11.8 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- 13.2 Geographic comparison
- 13.3 North America - Market size and forecast 2025-2030
- 13.3.1 US - Market size and forecast 2025-2030
- 13.3.2 Canada - Market size and forecast 2025-2030
- 13.3.3 Mexico - Market size and forecast 2025-2030
- 13.4 Europe - Market size and forecast 2025-2030
- 13.4.1 Germany - Market size and forecast 2025-2030
- 13.4.2 UK - Market size and forecast 2025-2030
- 13.4.3 France - Market size and forecast 2025-2030
- 13.4.4 Italy - Market size and forecast 2025-2030
- 13.4.5 Spain - Market size and forecast 2025-2030
- 13.4.6 The Netherlands - Market size and forecast 2025-2030
- 13.5 Asia - Market size and forecast 2025-2030
- 13.5.1 China - Market size and forecast 2025-2030
- 13.5.2 India - Market size and forecast 2025-2030
- 13.5.3 Japan - Market size and forecast 2025-2030
- 13.5.4 South Korea - Market size and forecast 2025-2030
- 13.5.5 Indonesia - Market size and forecast 2025-2030
- 13.5.6 Thailand - Market size and forecast 2025-2030
- 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 13.6.1 Brazil - Market size and forecast 2025-2030
- 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 13.6.3 UAE - Market size and forecast 2025-2030
- 13.6.4 Turkey - Market size and forecast 2025-2030
- 13.6.5 Argentina - Market size and forecast 2025-2030
- 13.6.6 Colombia - Market size and forecast 2025-2030
- 13.6.7 South Africa - Market size and forecast 2025-2030
- 13.6.8 Israel - Market size and forecast 2025-2030
- 13.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
- 14.1 Market drivers
- Rising incidence of target infectious diseases and global pathogen outbreaks
- Accelerated proliferation of antimicrobial resistance and public health mandates
- Technological integration of molecular assays and point of care testing innovation
- 14.2 Market challenges
- Substantial capital demands and prohibitive manufacturing costs of advanced diagnostic instrumentation
- Critical shortage of skilled laboratory personnel and infrastructure deficiencies
- Stringent and protracted regulatory approval pathways across international jurisdictions
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 14.4 Market opportunities
- Shift towards high-throughput syndromic multiplex testing panels
- Expansion of AI and ML in decentralized phenotypic profiling
- Accelerated proliferation of microfluidic POC assays and regulatory harmonization
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- Companies covered
- 16.2 Company ranking index
- Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
- 16.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 16.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 16.8 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 16.9 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
- 16.10 Cepheid Inc.
- Cepheid Inc. - Overview
- Cepheid Inc. - Product / Service
- Cepheid Inc. - Key offerings
- SWOT
- 16.11 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 16.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.13 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Product / Service
- Hologic Inc. - Key offerings
- SWOT
- 16.14 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 16.15 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 16.16 Seegene Inc.
- Seegene Inc. - Overview
- Seegene Inc. - Product / Service
- Seegene Inc. - Key offerings
- SWOT
- 16.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 16.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- Research methodology
- 17.5 Data procurement
- Information sources
- 17.6 Data validation
- Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
- List of abbreviations
